Madrigal Pharmaceuticals, Inc. (MDGL)

473.24 -24.80 (-4.98%) USD  |  NASDAQ  |  Jan 23, 12:37
More

Madrigal Pharmaceuticals Non-Operating Interest Expense (Quarterly)

Non-Operating Interest Expense (Quarterly) Chart

View Non-Operating Interest Expense (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Operating Interest Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Operating Interest Expense (Quarterly) Range, Past 5 Years

View Non-Operating Interest Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Operating Interest Expense (Quarterly) Benchmarks

View Non-Operating Interest Expense (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade